Mercury Laboratories Limited Share Price

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.As of 25 May 2026, Mercury Laboratories Limited share price is ₹888.30. The stock opened at ₹773.00, compared to its previous close of ₹740.25. During today's trading session, Mercury Laboratories Limited share price moved in the range of ₹773.00 to ₹888.30, with an average price of ₹830.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹773.00 and a high of ₹888.30.

The market capitalization of Mercury Laboratories Limited is ₹89 Crs, with a P/E ratio of 18.8 and a dividend yield of 0.47%.